CYPH (Cypherpunk Technologies) Other Stockholders Equity: $-0.00 Mil (As of Mar. 2026)


CYPH Cypherpunk Technologies Inc CYPH
34 GF Score
Price $0.70
! 3 Warning Signs
View Full Analysis

What is Cypherpunk Technologies Other Stockholders Equity?

Cypherpunk Technologies CYPH +0.41% 34 Other Stockholders Equity is $-0.00 Mil as of Mar. 2026. GuruFocus rates CYPH with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Cypherpunk Technologies's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $-0.00 Mil.

Cypherpunk Technologies's quarterly Other Stockholders Equity declined from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($-0.15 Mil) but then increased from Dec. 2025 ($-0.15 Mil) to Mar. 2026 ($-0.00 Mil).

Cypherpunk Technologies's annual Other Stockholders Equity increased from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($-0.00 Mil) but then declined from Dec. 2024 ($-0.00 Mil) to Dec. 2025 ($-0.15 Mil).

Cypherpunk Technologies Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cypherpunk Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cypherpunk Technologies Other Stockholders Equity Chart

Cypherpunk Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.00 -0.15

Cypherpunk Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 -0.15 -0.00
CYPH
34GF Score
Cypherpunk Technologies Inc CYPH
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cypherpunk Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Cypherpunk Technologies (CYPH) has a Other Stockholders Equity of $-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cypherpunk Technologies and its competitors.
Is Cypherpunk Technologies' Other Stockholders Equity too high?
Cypherpunk Technologies' current Other Stockholders Equity is $-0.00 Mil. Overall, Cypherpunk Technologies has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cypherpunk Technologies' Other Stockholders Equity compare to VLT and PGZ?
Cypherpunk Technologies' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Asset Management company?
A good Other Stockholders Equity depends on the Asset Management industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cypherpunk Technologies and its competitors. Cypherpunk Technologies's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cypherpunk Technologies stock overvalued right now?
Cypherpunk Technologies (CYPH) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Cypherpunk Technologies' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cypherpunk Technologies (CYPH), the current Other Stockholders Equity is $-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cypherpunk Technologies Business Description

Other Exchanges 5MC:Germany
Address 47 Thorndike Street, Suite B1-1, Cambridge, MA, USA, 02141
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
34GF Score

Get the complete analysis for CYPH

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price